TGD001 SAD study in healthy volunteers
This early-stage study is looking at a new medicine called TGD001. It's the very first time this medicine will be given to humans, specifically healthy volunteers. The main goal is to check how safe it is and how much of it stays in the body over time. We'll be giving different groups of men a single dose of either TGD001 or a dummy medicine (placebo). This helps us understand what effects the actual medicine has. Participants will be healthy men aged 18 and over. This kind of study is crucial for learning about new medicines before they can be tested in people who are ill.
At a glance
What is this study about?
This is an early research study, often called a Phase 1 trial. It's an important first step when a new medicine has been developed. Before any medicine can be used widely, it must go through several stages of testing to make sure it's safe and works as intended. This particular study, named TGD001 SAD, focuses on giving a single dose of the new medicine, TGD001, to healthy people.
The main reasons for doing this study are to find out if TGD001 is safe when given to humans and how the body processes it. This includes seeing how much of the medicine gets into the bloodstream, how long it stays there, and how the body gets rid of it. Participants in the study will be split into groups, and each group will receive a different amount (dose) of TGD001. Some participants will also receive a 'placebo', which looks exactly like the medicine but contains no active ingredients. This helps researchers compare the effects of TGD001 against no treatment at all.
By carefully observing participants and taking measurements like blood samples, the researchers can gather vital information. This helps them understand whether TGD001 has any unexpected side effects and how different doses are handled by the body. This information is crucial for deciding if the medicine can move on to later stages of testing with people who have a specific illness, and to help determine the best dose to use.
Key takeaways
- This is the first human study of a new medicine called TGD001.
- The main goals are to check the medicine's safety and how the body handles it.
- Healthy men aged 18 and over can take part.
- Participants will receive a single dose of either TGD001 or a dummy medicine.
- Your participation helps advance medical research for future treatments.
Who may be eligible?
This study is looking for participants who are in good health. To take part, you need to be a man and aged 18 years or older. There is no upper age limit, so men of any age beyond 18 can be considered.
Being 'healthy' means that you don't have any serious ongoing medical conditions, and generally, your body is functioning well. The research team will do a thorough health check to make sure you fit this description before you can join.
Because this is a very early study of a new medicine, they are being very careful about who can participate to ensure the safety of everyone involved.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you male?
- Are you 18 years old or older?
- Are you generally in good health?
- Are you willing to follow study instructions and attend appointments?
What does participation involve?
If you decide to take part, you would receive a single dose of either the study medicine (TGD001) or a placebo (a dummy medicine). You wouldn't know which one you received, nor would the doctors – this is called 'double-blind'. You would have regular check-ups, which include physical exams, blood tests, and other measurements, to see how the medicine affects you and how your body handles it. The researchers would monitor you closely for any side effects. The exact number of visits and the total time frame of your participation would be explained in detail by the study team, but it would involve some time at the clinic for observations after receiving the dose and follow-up appointments.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What does 'Phase I' mean?
Phase I means this is the very first time the medicine is being tested in humans, usually healthy volunteers, to check its safety.
What is a 'placebo'?
A placebo is a dummy medicine that looks like the real treatment but contains no active ingredients. It helps researchers compare effects.
Why only healthy men?
Early studies often start with a very specific, healthy group to best understand how the medicine works in a predictable way before testing in broader populations or those with illnesses.
Will I get paid for taking part?
Many early-stage studies offer payment for your time and inconvenience. The study team will provide details on this.
How long will the study last for me?
The study team will explain the exact duration of your involvement, which includes screening, receiving the dose, and follow-up appointments.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.